An economic analysis of Chemo Mouthpiece® versus supportive care for the reduction of oral mucositis incidence in patients receiving chemotherapy.

PubMed 2026 Open access

Read full text
Authors: Richard Michael Zuniga, Aidan Dineen, Rosemarie Velasquez, Donghyun D. Lee, Anthony T. Zara, Bonni Tattoli, Megan Bourque, Frank Jacobucci
DOI: 10.57264/cer-2025-0164
Cited by: 0

Abstract

Adoption of CMP was projected to be associated with reduced OM-associated clinical events and healthcare resource use. For 1000 adults using CMP for one CT cycle, cost savings accumulated to over one million dollars, amounting to $1166 per patient. Results of the real-world base case indicated that the value of CMP is likely underestimated, with cost savings over 15 million dollars, amounting to $15,395 per patient.

Fields of Study & Subjects

Oral health in cancer treatment Health Systems Economic Evaluations Quality of Life Economic and Financial Impacts of Cancer

Publication details

Journal / source
PubMed
Volume
15
Issue
3
Pages
e250164–e250164
Publication date
1 March 2026
Language
EN